Osimertinib is used for treating NSCLC. It targets a specific type of mutation called EGFR T790M. You can get it in two doses: 40 mg and 80 mg, both are film-coated.
The usual dose is 80 mg once a day. It’s okay to take it with or without eating. You’ll find these in bottles with 30 tablets inside.
Osimertinib works to block something called EGFR T790M, which is really important for managing NSCLC when you have this specific mutation. You need to take it as your doctor tells you to get the best results. Always take it with medical supervision.
And whether you can use it depends on what the regulators say and if it’s right for you.
